Bausch + Lomb to Showcase Eye Health Strategies at Investor Conferences
ByAinvest
Friday, Aug 15, 2025 12:50 am ET1min read
BLCO--
The first conference is the J.P. Morgan European Leveraged Finance Conference, scheduled for September 3, 2025, in London, U.K. Executive Vice President and Chief Financial Officer Sam Eldessouky will participate in investor meetings at this event. The second conference is the Morgan Stanley Global Healthcare Conference, set for September 8, 2025, at 7:45 a.m. ET in New York, NY. Chairman of the Board and Chief Executive Officer Brent Saunders and Sam Eldessouky will engage in a fireside chat at this conference. A live webcast of the Morgan Stanley fireside chat will be available on the Bausch + Lomb Investor Relations website.
Bausch + Lomb, founded in 1853, has a comprehensive portfolio of approximately 400 eye health products, including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. The company operates with a global footprint, employing around 13,500 people in approximately 100 countries. Headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey, Bausch + Lomb is committed to protecting and enhancing the gift of sight for millions of people worldwide.
These conferences are an opportunity for investors to engage directly with Bausch + Lomb's leadership and gain a deeper understanding of the company's strategic initiatives and financial outlook.
References:
[1] https://www.businesswire.com/news/home/20250814107491/en/Bausch-Lomb-to-Participate-in-Upcoming-Investor-Conferences
Bausch + Lomb will participate in two investor conferences in September 2025, with top executives engaging in meetings and discussions in London and New York. The Morgan Stanley conference will be live webcast for viewing. The company, founded in 1853, has a portfolio of approximately 400 eye health products and a global presence with around 13,500 employees operating in around 100 countries.
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced its participation in two significant investor conferences in September 2025. The events will provide investors with opportunities to gain insights into the company's strategic direction and financial performance.The first conference is the J.P. Morgan European Leveraged Finance Conference, scheduled for September 3, 2025, in London, U.K. Executive Vice President and Chief Financial Officer Sam Eldessouky will participate in investor meetings at this event. The second conference is the Morgan Stanley Global Healthcare Conference, set for September 8, 2025, at 7:45 a.m. ET in New York, NY. Chairman of the Board and Chief Executive Officer Brent Saunders and Sam Eldessouky will engage in a fireside chat at this conference. A live webcast of the Morgan Stanley fireside chat will be available on the Bausch + Lomb Investor Relations website.
Bausch + Lomb, founded in 1853, has a comprehensive portfolio of approximately 400 eye health products, including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. The company operates with a global footprint, employing around 13,500 people in approximately 100 countries. Headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey, Bausch + Lomb is committed to protecting and enhancing the gift of sight for millions of people worldwide.
These conferences are an opportunity for investors to engage directly with Bausch + Lomb's leadership and gain a deeper understanding of the company's strategic initiatives and financial outlook.
References:
[1] https://www.businesswire.com/news/home/20250814107491/en/Bausch-Lomb-to-Participate-in-Upcoming-Investor-Conferences

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet